Volume 26, Issue 10 pp. 2002-2005
SHORT COMMUNICATION

One-step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement

Giulio Cuffolo MBBS, BSc

Corresponding Author

Giulio Cuffolo MBBS, BSc

Department of Breast Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Correspondence

Giulio Cuffolo, Department of Breast Surgery, Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford, UK.

Email: [email protected]

Search for more papers by this author
Harvinder K. Gahir-Atwal MSc

Harvinder K. Gahir-Atwal MSc

Department of Pathology, Royal Berkshire NHS Foundation Trust, Reading, UK

Search for more papers by this author
Brendan Smith MBBS, MS

Brendan Smith MBBS, MS

Department of Breast Surgery, Royal Berkshire NHS Foundation Trust, Reading, UK

Search for more papers by this author
First published: 17 July 2020
Citations: 3

Abstract

We evaluated novel sentinel node values in breast cancer for one-step nucleic acid amplification (OSNA) to predict further nodal involvement using various methods in clinically node-negative disease with a positive OSNA result and subsequent axillary node dissection. 239 patients (118 macrometastatic) were assessed revealing cutoffs of total tumor load (TTL) 44 500 copies/µL (AUROC 0.793); average copy number (ACN) 9450 (AUROC 0.790); and highest copy number (HCN) 46,000. For macrometastatic patients only: TTL 221 400 copies/µL (AUROC 0.685); ACN 64,000 (AUROC 0.671); HCN 59 500 (AUROC 0.529). Our data favor TTL and represent one of the largest OSNA macrometastatic predictive series.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.